Communiqués Ventripoint Diagnostics Ltd. OTC Markets

Actions

VPTDF

CA92281P2008

Equipement et technologie médicale avancés

Temps Différé OTC Markets 18:52:28 08/10/2026			Varia. 5j.	Varia. 1 janv.
0,0612 ^USD	-0,87%		+1,49%	-41,44%

01/09	Ventripoint Diagnostics Ltd. publie ses résultats pour le semestre clos le 30 juin 2026	CI
20/08	Unidoc Health Corp. signe un protocole d'accord avec Ventripoint Diagnostics pour évaluer une plateforme de dépistage et d'évaluation cardiaque à distance	CI

Communiqués

06/10	Ventripoint Provides Corporate Update and Announces Shareholder Videoconference Call	AQ
14/09	Ventripoint Issues Shares for Payment of Debenture Interest	AQ
20/08	UniDoc Health Signs MOU with Ventripoint Diagnostics to Evaluate Remote Cardiac Assessment and Screening Platform	AQ
12/08	Ventripoint Expands Subscription Access for FDA-Cleared AI Cardiac Imaging	GL
07/08	Ventripoint Diagnostics Announces Cancellation and Re-Grant of Options, Grant of Annual Incentive Options and Private Placement	AQ
05/08	UniDoc Health and Ventripoint Diagnostics Sign MOU to Evaluate Scalable Remote Cardiac Assessment and Screening Platform	AQ
22/07	Ventripoint Issue Shares for Payment of Debenture Interest	AQ
22/07	Ventripoint Engages More Capital Ltd.	AQ
20/07	Ventripoint Diagnostics' VMS+ Technology Selected for World-First AI Cardiac Monitoring Study in Breast Cancer Patients	AQ
26/06	Ventripoint and Ollie Hinkle Heart Foundation Partner to Expand Access to AI-Powered Heart Imaging for Children Living with Heart Disease	AQ
15/06	Ventripoint Diagnostics Announces Support for the Global Congenital Heart Disease Alliance	AQ
30/05	Ventripoint Announces Adoption of Semi-Annual Reporting (SAR)	AQ
25/05	Ventripoint Provides Videoconference Link to Annual General Meeting and Corporate Update	AQ
19/05	Cardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial Fronts	PR
19/05	Ventripoint Issues Shares for Payment of Debenture Interest	AQ
13/05	A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech	AQ
12/05	The $59B Quiet Shift Reshaping How Patients Access Care	PR
12/05	Wall Street's Cardiac Bet: Where Diagnostics Meet the Money	PR
04/05	Ventripoint to Exhibit at the 59th Annual Meeting of the Association for European Paediatric and Congenital Cardiology	AQ
29/04	Why Medtech Giants Are Quietly Paying Up for AI Diagnostics	PR
29/04	The Quiet Rule Change Tilting $10B Toward Medtech's Most Validated Platforms	PR
29/04	Ventripoint Diagnostics : Issues Shares for Debt Settlement and Awards Option Grants	PU
28/04	Ventripoint's VMS+ (TM) 4.0 Submitted for Regulatory Approval in China by Lishman Global Inc.	AQ
22/04	Ventripoint Issue Shares for Payment of Debenture Interest	AQ
20/04	Ventripoint's VMS+(TM) 4.0 Recognized with Gold Edison Award, Validating Leadership and Future Potential	AQ